214 related articles for article (PubMed ID: 14503997)
1. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community.
Shemesh T; Piers LS; O'Dea K
Ann Clin Biochem; 2003 Sep; 40(Pt 5):566-8. PubMed ID: 14503997
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
[TBL] [Abstract][Full Text] [Related]
3. Agreement between HbA1c measured by DCA 2000 and by HPLC: effects of fetal hemoglobin concentrations.
Diem P; Wälchli M; Mullis PE; Marti U
Arch Med Res; 2004; 35(2):145-9. PubMed ID: 15010195
[TBL] [Abstract][Full Text] [Related]
4. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
5. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
6. Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin.
Miyazaki A; Kohzuma T; Kasayama S; Koga M
Ann Clin Biochem; 2012 Sep; 49(Pt 5):441-4. PubMed ID: 22715294
[TBL] [Abstract][Full Text] [Related]
7. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
8. Continuous glucose monitoring and haemoglobin A(1c).
Sharp P; Rainbow S
Ann Clin Biochem; 2002 Sep; 39(Pt 5):516-7. PubMed ID: 12227860
[TBL] [Abstract][Full Text] [Related]
9. A case of discordant HbA(1c): a method-dependent error.
Dimeski G; Pretorius CJ; Russell AW; Miller SP; Bird RJ; Ungerer JP
Med J Aust; 2009 Sep; 191(6):347-9. PubMed ID: 19769560
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
11. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
Pupillo M; De Berardis G; Antenucci D; Minnucci A; Nicolucci A
Diabetes Res Clin Pract; 2008 Jun; 80(3):e1-3. PubMed ID: 18258329
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the practicability and analytical performance of a point-of-care affinity chromatography haemoglobin A1c analyser for use in the non-laboratory setting.
Shephard M; Whiting M
Ann Clin Biochem; 2006 Nov; 43(Pt 6):513-5. PubMed ID: 17132286
[TBL] [Abstract][Full Text] [Related]
14. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
15. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
Berg AH; Sacks DB
J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.
Tanaka Y; Atsumi Y; Matsuoka K; Mokubo A; Asahina T; Hosokawa K; Shimada S; Matsunaga H; Takagi M; Ogawa O; Onuma T; Kawamori R
Diabetes Res Clin Pract; 2001 Jul; 53(1):41-5. PubMed ID: 11378212
[TBL] [Abstract][Full Text] [Related]
17. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
18. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.
Sung KC; Rhee EJ
Diabet Med; 2007 Aug; 24(8):848-54. PubMed ID: 17650158
[TBL] [Abstract][Full Text] [Related]
19. Derivation & validation of glycosylated haemoglobin (HbA
Mohan A; Reddy SA; Sachan A; Sarma K; Kumar DP; Panchagnula MV; Rao PS; Kumar BS; Krishnaprasanthi P
Indian J Med Res; 2016 Aug; 144(2):220-228. PubMed ID: 27934801
[TBL] [Abstract][Full Text] [Related]
20. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
